Sign in
CompletedPhase 4

Effect of Bioflor on Gut Microbiota in Proton-Pump Inhibitor Users

Key facts

Who runs it
Seoul National University Hospital
Where
South Korea3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
80 people enrolled
Started
18 Jul 2024
Ended
18 Sept 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Saccharomyces Boulardii 250 MG
  • Proton Pump Inhibitors (PPI)
Record updated
1 October 2026

Who can take part

Age
19 years to 79 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Voluntary written informed consent to participate in this clinical trial
  • Age 19 to 79 years
  • No history of PPI use within 2 months prior to obtaining consent
  • BMI between 18.5 and 30.0 kg/m², and body weight ≥ 50 kg

Who cannot take part

  • Antibiotic use within the prior 3 months
  • Use of mucosal protective agents, NSAIDs, probiotics, or other agents/drugs altering gut microbiota function, lactulose, other antacids, GI motility-enhancing agents, or enemas within the prior 4 weeks
  • Antifungal medication use within 14 days prior to enrollment
  • History of Clostridioides difficile infection within 2 years prior to enrollment
  • Significant change in dietary habits within 30 days prior to study participation, as assessed by the investigator
  • New drug prescription within 2 weeks prior to enrollment
  • History of gastrointestinal or abdominal surgery
  • Immunocompromised individuals, or history of inflammatory bowel disease (Crohn's disease or ulcerative colitis)
  • Any other condition that, in the investigator's judgment, makes the participant unsuitable for study participation
  • Pregnant or breastfeeding women
  • Presence of a central venous catheter
  • Current smoker

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Proton-pump inhibitors (PPIs) are widely used to treat acid-related stomach problems, such as heartburn and acid reflux. Long-term use of PPIs has been linked to changes in the gut bacteria and fungi (called the gut microbiota), which may contribute to digestive side effects. Bioflor® is a probiotic product containing a yeast called Saccharomyces boulardii, which has been used to help with various digestive problems. However, little is known about how Bioflor affects the gut microbiota in people who are taking PPIs.

Read full original descriptionShow less

This study enrolled three groups of adults at four hospitals/research centers in Korea: a control group without digestive symptoms who were not taking a PPI, a group of patients with reflux symptoms who started taking a PPI alone, and a group of patients who started taking a PPI together with Bioflor for 8 weeks. Participants completed symptom questionnaires and provided stool samples before and after treatment, which were analyzed to study changes in gut bacteria and fungi.

The purpose of this study was to compare gut microbiota composition and digestive symptoms between PPI users who did and did not take Bioflor, in order to better understand the role of Bioflor in people taking PPIs.

The 3 groups in the trial

  • ControlNo study treatment, for comparison

    Healthy participants without GERD symptoms or need for PPI treatment. The Control group is not subject to randomization.

  • Case1Existing treatment, for comparison

    Patients with GERD/NERD symptoms starting PPI treatment, without Bioflor. Randomized 1:1 with Case 2.

    Treatment: Proton Pump Inhibitors (PPI)

  • Case2Treatment being tested

    Patients with GERD/NERD symptoms starting PPI treatment combined with Bioflor (2 capsules twice daily for 8 weeks). Randomized 1:1 with Case 1.

    Treatment: Saccharomyces Boulardii 250 MG and Proton Pump Inhibitors (PPI)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Saccharomyces Boulardii Probiotics (Bioflor®) on Gut Microbiota in Proton-pump Inhibitor User
Record updated
1 October 2026